A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis
- 3k Downloads
The purpose of this study is to review the effects of low-level laser therapy (LLLT) in the prevention and treatment of cancer therapy-induced oral mucositis (OM).
A systematic review and meta-analysis of randomised placebo-controlled trials of LLLT performed during chemotherapy or radiation therapy in head and neck cancer patients.
We found 11 randomised placebo-controlled trials with a total of 415 patients; methodological quality was acceptable at 4.10 (SD ± 0.74) on the 5-point Jadad scale. The relative risk (RR) for developing OM was significantly (p = 0.02) reduced after LLLT compared with placebo LLLT (RR = 2.03 (95% CI, 1.11 to 3.69)). This preventive effect of LLLT improved to RR = 2.72 (95% CI, 1.98 to 3.74) when only trials with adequate doses above 1 J were included. For treatment of OM ulcers, the number of days with OM grade 2 or worse was significantly reduced after LLLT to 4.38 (95% CI, 3.35 to 5.40) days less than placebo LLLT. Oral mucositis severity was also reduced after LLLT with a standardised mean difference of 1.33 (95% CI, 0.68 to 1.98) over placebo LLLT. All studies registered possible side-effects, but they were not significantly different from placebo LLLT.
There is consistent evidence from small high-quality studies that red and infrared LLLT can partly prevent development of cancer therapy-induced OM. LLLT also significantly reduced pain, severity and duration of symptoms in patients with cancer therapy-induced OM.
KeywordsLow-level laser therapy Oral mucositis Cancer Chemotherapy Radiation therapy
Post-mortem to professor Anne Elisabeth Ljunggren for her encouragement and contribution to the early work on this manuscript. Unfortunately, she was unable to see its completion.
Conflicts of interest
- 1.Manas A, Palacios A, Contreras J, Sanchez-Magro I, Blanco P, Fernandez-Perez C (2009) Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study). Clin Transl Oncol 11:669–676PubMedCrossRefGoogle Scholar
- 2.Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113:2704–2713PubMedCrossRefGoogle Scholar
- 4.Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A et al (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer 113:1446–1452PubMedCrossRefGoogle Scholar
- 6.Worthington HV, Clarkson JE, Eden OB (2007) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. CD000978Google Scholar
- 8.Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L et al (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031–1035PubMedCrossRefGoogle Scholar
- 15.Leal Junior EC, Lopes-Martins RA, Frigo L, De Marchi T, Rossi RP, de Godoi V et al (2010) Effects of Low-level laser therapy (LLLT) in the development of exercise-induced skeletal muscle fatigue and changes in biochemical markers related to post-exercise recovery. J Orthop Sports Phys Ther 40(8):524–532PubMedGoogle Scholar
- 21.Cohen J (1977) Statistical power analysis for behavioural sciences. Academic, New YorkGoogle Scholar
- 30.Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C et al (1997) Low energy helium–neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38:697–703PubMedCrossRefGoogle Scholar
- 31.Genot-Klastersky MT, Klastersky J, Awada F, Awada A, Crombez P, Martinez MD et al (2008) The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer 16:1381–1387PubMedCrossRefGoogle Scholar
- 34.Schubert MM, Eduardo FP, Guthrie KA, Franquin JC, Bensadoun RJ, Migliorati CA et al (2007) A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15:1145–1154PubMedCrossRefGoogle Scholar
- 35.Kuhn A, Vacaro G, Almeida D, Machado A, Braghini PB, Shilling MA et al (2007) Low-level infrared laser therapy for chemo- or radiation-induced oral mucositis: a randomized placebo-controlled study. J Oral Laser Applications 7:175–181Google Scholar
- 36.Chor A, Torres SR, Maiolino A, Nucci M (2010) Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation. Eur J Haematol 4:78–79Google Scholar
- 37.Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 8:CD001973.Google Scholar
- 39.Brosseau L, Robinson V, Wells G, Debie R, Gam A, Harman K et al. (2005) Low level laser therapy (classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev CD002049.Google Scholar